BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu HT, Hassounah SA, Colby-Germinario SP, Oliveira M, Fogarty C, Quan Y, Han Y, Golubkov O, Ibanescu I, Brenner B, Stranix BR, Wainberg MA. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors. J Antimicrob Chemother 2017;72:727-34. [PMID: 28069884 DOI: 10.1093/jac/dkw514] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Liang R, Gao Y, Li Y, Deng X, Xiang R, Zhang Y, Ying T, Jiang S, Yu F. Development of Small-Molecule Inhibitors Against Zika Virus Infection. Front Microbiol 2019;10:2725. [PMID: 31866959 DOI: 10.3389/fmicb.2019.02725] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
2 Elshahawi H, Syed Hassan S, Balasubramaniam V. Importance of Zika Virus NS5 Protein for Viral Replication. Pathogens 2019;8:E169. [PMID: 31574966 DOI: 10.3390/pathogens8040169] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
3 Gong P. Within and Beyond the Nucleotide Addition Cycle of Viral RNA-dependent RNA Polymerases. Front Mol Biosci 2022;8:822218. [DOI: 10.3389/fmolb.2021.822218] [Reference Citation Analysis]
4 Dinesh DC, Tamilarasan S, Rajaram K, Bouřa E. Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases. Curr Drug Targets 2020;21:105-24. [PMID: 31538891 DOI: 10.2174/1389450119666190920153247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
5 Eyer L, Nougairède A, Uhlířová M, Driouich JS, Zouharová D, Valdés JJ, Haviernik J, Gould EA, De Clercq E, de Lamballerie X, Ruzek D. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice. J Virol 2019;93:e00367-19. [PMID: 31142664 DOI: 10.1128/JVI.00367-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
6 Sundar S, Piramanayagam S, Natarajan J. A review on structural genomics approach applied for drug discovery against three vector-borne viral diseases: Dengue, Chikungunya and Zika. Virus Genes 2022. [PMID: 35394596 DOI: 10.1007/s11262-022-01898-5] [Reference Citation Analysis]
7 Sáez-Álvarez Y, Arias A, Del Águila C, Agudo R. Development of a fluorescence-based method for the rapid determination of Zika virus polymerase activity and the screening of antiviral drugs. Sci Rep 2019;9:5397. [PMID: 30932009 DOI: 10.1038/s41598-019-41998-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
8 Selisko B, Papageorgiou N, Ferron F, Canard B. Structural and Functional Basis of the Fidelity of Nucleotide Selection by Flavivirus RNA-Dependent RNA Polymerases. Viruses 2018;10:E59. [PMID: 29385764 DOI: 10.3390/v10020059] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
9 Venkateshan M, Muthu M, Suresh J, Ranjith Kumar R. Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis, physicochemical, quantum chemical, modeling and molecular docking analysis. J Mol Struct 2020;1220:128741. [PMID: 32834110 DOI: 10.1016/j.molstruc.2020.128741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
10 Nourian A, Khalili H. Sofosbuvir as a potential option for the treatment of COVID-19. Acta Biomed 2020;91:236-8. [PMID: 32420958 DOI: 10.23750/abm.v91i2.9609] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Sze A, Olagnier D, Hadj SB, Han X, Tian XH, Xu HT, Yang L, Shi Q, Wang P, Wainberg MA, Wu JH, Lin R. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference. Viruses 2017;9:E287. [PMID: 28972551 DOI: 10.3390/v9100287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
12 Alves MP, Vielle NJ, Thiel V, Pfaender S. Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection. Viruses 2018;10:E593. [PMID: 30380760 DOI: 10.3390/v10110593] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
13 Mottin M, Caesar LK, Brodsky D, Mesquita NC, de Oliveira KZ, Noske GD, Sousa BK, Ramos PR, Jarmer H, Loh B, Zorn KM, Foil DH, Torres PM, Guido RV, Oliva G, Scholle F, Ekins S, Cech NB, Andrade CH, Laster SM. Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins. Bioorganic Chemistry 2022;120:105649. [DOI: 10.1016/j.bioorg.2022.105649] [Reference Citation Analysis]
14 Bernatchez JA, Coste M, Beck S, Wells GA, Luna LA, Clark AE, Zhu Z, Hecht D, Rich JN, Sohl CD, Purse BW, Siqueira-Neto JL. Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells. Viruses 2019;11:E365. [PMID: 31010044 DOI: 10.3390/v11040365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Saiz JC, Martín-Acebes MA, Bueno-Marí R, Salomón OD, Villamil-Jiménez LC, Heukelbach J, Alencar CH, Armstrong PK, Ortiga-Carvalho TM, Mendez-Otero R, Rosado-de-Castro PH, Pimentel-Coelho PM. Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic? Front Microbiol 2017;8:1554. [PMID: 28878742 DOI: 10.3389/fmicb.2017.01554] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
16 Pandeya KB, Ganeshpurkar A, Mishra MK. Natural RNA dependent RNA polymerase inhibitors: Molecular docking studies of some biologically active alkaloids of Argemone mexicana. Med Hypotheses 2020;144:109905. [PMID: 32535456 DOI: 10.1016/j.mehy.2020.109905] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
17 Kumar R, Mishra S, Shreya, Maurya SK. Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses. RSC Med Chem 2021;12:306-20. [PMID: 34046618 DOI: 10.1039/d0md00318b] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Calmels C, Ventura M, Aknin C, Métifiot M, Andreola ML. De novo RNA synthesis catalyzed by the Zika Virus RNA polymerase domain. Sci Rep 2017;7:2697. [PMID: 28577343 DOI: 10.1038/s41598-017-03038-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Parvez MSA, Karim MA, Hasan M, Jaman J, Karim Z, Tahsin T, Hasan MN, Hosen MJ. Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach. Int J Biol Macromol 2020;163:1787-97. [PMID: 32950529 DOI: 10.1016/j.ijbiomac.2020.09.098] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
20 Albentosa-González L, Clemente-Casares P, Sabariegos R, Mas A. Polymerase Activity, Protein-Protein Interaction, and Cellular Localization of the Usutu Virus NS5 Protein. Antimicrob Agents Chemother 2019;64:e01573-19. [PMID: 31685463 DOI: 10.1128/AAC.01573-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Eyer L, Kondo H, Zouharova D, Hirano M, Valdés JJ, Muto M, Kastl T, Kobayashi S, Haviernik J, Igarashi M, Kariwa H, Vaculovicova M, Cerny J, Kizek R, Kröger A, Lienenklaus S, Dejmek M, Nencka R, Palus M, Salat J, De Clercq E, Yoshii K, Ruzek D. Escape of Tick-Borne Flavivirus from 2'-C-Methylated Nucleoside Antivirals Is Mediated by a Single Conservative Mutation in NS5 That Has a Dramatic Effect on Viral Fitness. J Virol 2017;91:e01028-17. [PMID: 28814513 DOI: 10.1128/JVI.01028-17] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
22 Zhu S, Zhang C, Huang LS, Zhang XQ, Xu Y, Fang X, Zhou J, Wu M, Schooley RT, Huang Z, An J. Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors. Molecules 2019;24:E1465. [PMID: 31013906 DOI: 10.3390/molecules24081465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Baturcam E, Vollmer S, Schlüter H, Maciewicz RA, Kurian N, Vaarala O, Ludwig S, Cunoosamy DM. MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT/p70S6K/4E-BP1 signalling. Cell Commun Signal 2019;17:78. [PMID: 31319869 DOI: 10.1186/s12964-019-0378-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
24 Wang X, Zou P, Wu F, Lu L, Jiang S. Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses. Front Med 2017;11:449-61. [PMID: 29170916 DOI: 10.1007/s11684-017-0589-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
25 Boccuto A, Dragoni F, Picarazzi F, Lai A, Della Ventura C, Veo C, Giammarino F, Saladini F, Zehender G, Zazzi M, Mori M, Vicenti I. Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro. Int J Mol Sci 2021;22:2670. [PMID: 33800884 DOI: 10.3390/ijms22052670] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Xu H, Cheng M, Chi X, Liu X, Zhou J, Lin T, Yang W. High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection. J Virol 2019;93:e00758-19. [PMID: 31270223 DOI: 10.1128/JVI.00758-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
27 Picarazzi F, Vicenti I, Saladini F, Zazzi M, Mori M. Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge. Molecules 2020;25:E5695. [PMID: 33287144 DOI: 10.3390/molecules25235695] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
28 Rusanov T, Kent T, Saeed M, Hoang TM, Thomas C, Rice CM, Pomerantz RT. Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication. Sci Rep 2018;8:17384. [PMID: 30478404 DOI: 10.1038/s41598-018-35511-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Bernatchez JA, Tran LT, Li J, Luan Y, Siqueira-Neto JL, Li R. Drugs for the Treatment of Zika Virus Infection. J Med Chem 2020;63:470-89. [PMID: 31549836 DOI: 10.1021/acs.jmedchem.9b00775] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
30 Song W, Zhang H, Zhang Y, Chen Y, Lin Y, Han Y, Jiang J. Identification and Characterization of Zika Virus NS5 Methyltransferase Inhibitors. Front Cell Infect Microbiol 2021;11:665379. [PMID: 33898335 DOI: 10.3389/fcimb.2021.665379] [Reference Citation Analysis]
31 Xu HT, Colby-Germinario SP, Hassounah SA, Fogarty C, Osman N, Palanisamy N, Han Y, Oliveira M, Quan Y, Wainberg MA. Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication<sup/>. Sci Rep 2017;7:6345. [PMID: 28740124 DOI: 10.1038/s41598-017-06612-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
32 Song W, Zhang H, Zhang Y, Li R, Han Y, Lin Y, Jiang J. Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection. Front Med 2021;15:404-15. [PMID: 33369711 DOI: 10.1007/s11684-021-0834-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Zhou B, Ren YH, Han YS, Mesplède T, Yue JM. Diverse Types of Diterpenoids with an Aromatized C Ring from the Twigs of Podocarpus imbricatus. J Nat Prod 2020;83:2416-24. [PMID: 32786878 DOI: 10.1021/acs.jnatprod.0c00291] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Eyer L, Nencka R, de Clercq E, Seley-Radtke K, Růžek D. Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses. Antivir Chem Chemother 2018;26:2040206618761299. [PMID: 29534608 DOI: 10.1177/2040206618761299] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 17.7] [Reference Citation Analysis]
35 El Sahili A, Lescar J. Dengue Virus Non-Structural Protein 5. Viruses 2017;9:E91. [PMID: 28441781 DOI: 10.3390/v9040091] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
36 Mottin M, Borba JVVB, Braga RC, Torres PHM, Martini MC, Proenca-Modena JL, Judice CC, Costa FTM, Ekins S, Perryman AL, Horta Andrade C. The A-Z of Zika drug discovery. Drug Discov Today 2018;23:1833-47. [PMID: 29935345 DOI: 10.1016/j.drudis.2018.06.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]